Jun-zhi Wang-Junzhi
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies.
Journal: Signal transduction and targeted therapy
Published: March 10, 2025
Mucosal immunity and vaccine development.
Journal: Signal transduction and targeted therapy
Published: February 10, 2025
A novel alternative for pyrogen detection based on a transgenic cell line.
Journal: Signal transduction and targeted therapy
Published: June 07, 2023
Development and application of potency assays based on genetically modified cells for biological products.
Journal: Journal of pharmaceutical and biomedical analysis
Published: February 09, 2023
Determination of the biodistribution of chimeric antigen receptor-modified T cells against CD19 in NSG mice.
Journal: Methods in cell biology
Published: February 14, 2022
A bivalent recombinant vaccine: a promising strategy against both SARS-CoV-2 variants and wild type of the virus.
Journal: Signal transduction and targeted therapy
Published: May 05, 2021
COVID-19 vaccines: progress and understanding on quality control and evaluation.
Journal: Signal transduction and targeted therapy
Published: March 22, 2021
New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein.
Journal: Cellular & molecular immunology
Published: August 05, 2020
Development of reporter gene assays to determine the bioactivity of biopharmaceuticals.
Journal: Biotechnology advances
Published: April 29, 2019
Evaluation of environment safety of a Japanese encephalitis live attenuated vaccine.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: March 27, 2019
Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE.
Journal: Molecules (Basel, Switzerland)
Published: February 18, 2019
Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
Journal: Vaccine
Published: January 09, 2019
Last Updated: 09/26/2026